BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1679963)

  • 21. [Alterations of c-Myc and c-erbB-2 genes in ovarian tumours].
    Pastor T; Popović B; Gvozdenović A; Boro A; Petrović B; Novaković I; Puzović D; Luković L; Milasin J
    Srp Arh Celok Lek; 2009; 137(1-2):47-51. PubMed ID: 19370966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas.
    Walker RA; Senior PV; Jones JL; Critchley DR; Varley JM
    J Pathol; 1989 Jun; 158(2):97-105. PubMed ID: 2569035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential expression and cooperative interaction of c-Ha-ras and c-erbB genes in in vivo chemical carcinogenesis.
    Husain Z; Fei YB; Roy S; Solt DB; Polverini PJ; Biswas DK
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1264-8. PubMed ID: 2493153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell growth regulation in epithelial ovarian cancer.
    Bast RC; Boyer CM; Jacobs I; Xu FJ; Wu S; Wiener J; Kohler M; Berchuck A
    Cancer; 1993 Feb; 71(4 Suppl):1597-601. PubMed ID: 8431895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of HER-2/neu amplification and expression in tumor tissue and cultured cells using a simple, phenol free method for nucleic acid isolation.
    Kury FD; Schneeberger C; Sliutz G; Kubista E; Salzer H; Medl M; Leodolter S; Swoboda H; Zeillinger R; Spona J
    Oncogene; 1990 Sep; 5(9):1403-8. PubMed ID: 1699198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas.
    Park JB; Rhim JS; Park SC; Kimm SW; Kraus MH
    Cancer Res; 1989 Dec; 49(23):6605-9. PubMed ID: 2573419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amplification of c-myc and c-erbB-2 proto-oncogenes in human solid tumors: frequency and clinical significance.
    Gutman M; Ravia Y; Assaf D; Yamamoto T; Rozin R; Shiloh Y
    Int J Cancer; 1989 Nov; 44(5):802-5. PubMed ID: 2573579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amplification of c-myc but not of c-erbB-2 is associated with high proliferative capacity in breast cancer.
    Kreipe H; Feist H; Fischer L; Felgner J; Heidorn K; Mettler L; Parwaresch R
    Cancer Res; 1993 Apr; 53(8):1956-61. PubMed ID: 8096798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of cellular oncogenes in primary cells from human acute leukemias.
    Mavilio F; Sposi NM; Petrini M; Bottero L; Marinucci M; De Rossi G; Amadori S; Mandelli F; Peschle C
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4394-8. PubMed ID: 3520570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced expression of c-myc and decreased expression of c-fos protooncogenes in chemically and radiation-transformed C3H/10T1/2 Cl 8 mouse embryo cell lines.
    Shuin T; Billings PC; Lillehaug JR; Patierno SR; Roy-Burman P; Landolph JR
    Cancer Res; 1986 Oct; 46(10):5302-11. PubMed ID: 2875790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis.
    Børresen AL; Ottestad L; Gaustad A; Andersen TI; Heikkilä R; Jahnsen T; Tveit KM; Nesland JM
    Br J Cancer; 1990 Oct; 62(4):585-90. PubMed ID: 1977466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma.
    Tavassoli M; Quirke P; Farzaneh F; Lock NJ; Mayne LV; Kirkham N
    Br J Cancer; 1989 Oct; 60(4):505-10. PubMed ID: 2572268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH.
    Wang ZR; Liu W; Smith ST; Parrish RS; Young SR
    Exp Mol Pathol; 1999 Jun; 66(2):140-8. PubMed ID: 10409442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neu proto-oncogene amplification and expression in ovarian adenocarcinoma cell lines.
    King BL; Carter D; Foellmer HG; Kacinski BM
    Am J Pathol; 1992 Jan; 140(1):23-31. PubMed ID: 1346236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular protoonocogenes are infrequently amplified in untreated non-small cell lung cancer.
    Slebos RJ; Evers SG; Wagenaar SS; Rodenhuis S
    Br J Cancer; 1989 Jan; 59(1):76-80. PubMed ID: 2547415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
    Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T
    Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amplification of ERBB-2 (HER-2/NEU) oncogene in different neoplasms of patients from USSR.
    Knyazev PG; Imyanitov EN; Chernitca OI; Nikiforova IF; Hanson KP
    Oncology; 1992; 49(2):162-5. PubMed ID: 1349430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A unique pattern of proto-oncogene abnormalities in ovarian adenocarcinomas.
    Zhou DJ; Gonzalez-Cadavid N; Ahuja H; Battifora H; Moore GE; Cline MJ
    Cancer; 1988 Oct; 62(8):1573-6. PubMed ID: 3167770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.